Workflow
Argenx SE (NASDAQ:ARGX) Faces Setback in Phase 3 Thyroid Eye Disease Studies
Financial Modeling Prep· 2025-12-16 00:00
Core Insights - Argenx SE has discontinued its Phase 3 UplighTED studies for efgartigimod SC in adults with moderate to severe thyroid eye disease due to futility, as advised by an Independent Data Monitoring Committee [1][2] - The company plans to conduct a comprehensive analysis of the data post-study closure to inform future research in thyroid eye disease [2] - Despite this setback, Argenx remains committed to advancing its portfolio of novel antibody-based medicines and exploring therapies for serious autoimmune conditions [3] Financial Overview - Argenx's stock has experienced fluctuations, with a recent price target set at $1,248 by Stifel Nicolaus, indicating a potential increase of approximately 40.26% from the current price of $849.52 [4] - The stock has seen a decrease of about 3.24% or $28.43 recently, with a trading range between $827.52 and $853.96 during the day [4] - Over the past year, the stock reached a high of $934.62 and a low of $510.06, with a market capitalization of approximately $51.96 billion [5]
Why VinFast Auto Stock Motored Higher Today
The Motley Fool· 2025-12-16 00:00
The company's global ambitions are becoming ever more apparent.It was quite a memorable Monday in the short history of electric vehicle (EV) maker VinFast (VFS +5.15%). The company formally opened its first factory in Southeast Asia outside of its native Vietnam, and investors cheered the expansion. They collectively traded the company's U.S.-listed shares up by more than 5% on a generally gloomy day for the stock market. Indonesian expansionVinFast cut the ribbon on that new facility, located in Subang, In ...
East West Bancorp: A Niche Banking Opportunity Worth Considering
The Motley Fool· 2025-12-16 00:00
Anand Chokkavelu has no position in any of the stocks mentioned. Lou Whiteman has no position in any of the stocks mentioned. Matt Frankel, CFP has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. ...
Recent Market Analysis Highlights Top Losers
Financial Modeling Prep· 2025-12-16 00:00
Company Analysis - iRobot Corporation (IRBT) experienced a significant decline in share price to $1.29, down by $3.02 or 70.02%, potentially due to competitive pressures and global supply chain issues [2] - iRobot filed for Chapter 11 bankruptcy protection, indicating that under the Picea Robotics acquisition plan, current shareholders will be completely wiped out, which could lead to a 'Zombie Squeeze' scenario for the stock [2] - Luminar Technologies, Inc. (LAZR) saw its share price decrease to $0.38, a decline of $0.51 or 57.03%, as it operates in the highly speculative and competitive autonomous vehicle market [3] - Luminar also filed for Chapter 11 bankruptcy protection following layoffs, executive departures, and a legal dispute with its largest customer, Volvo [3] Industry Overview - The market movements reflect a combination of industry-specific challenges and broader economic conditions affecting investor confidence and stock valuations [4] - Significant price changes underscore the volatility and risks inherent in the stock market, particularly for companies in rapidly evolving industries or those facing unique operational challenges [4] - Investors and stakeholders in these companies will likely be closely monitoring for any developments that could influence future performance and market positions [4]
Why Zillow Stock Dropped Today
The Motley Fool· 2025-12-16 00:00
A formidable force is encroaching on the home listing leader's turf.Shares of Zillow Group (ZG 7.90%) (Z 8.47%) fell on Monday following reports that Alphabet was entering the online real estate arena. By the close of trading, Zillow's stock price was down roughly 8% after falling nearly 13% earlier in the day. A new competitive threat Google is reportedly adding home sale listings directly to its search results in select markets.The tech titan appears to be testing demand for the new features, which inclu ...
Carbon Streaming Announces Amendment to Azuero Reforestation Carbon Removal Stream
Globenewswire· 2025-12-16 00:00
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) today announce amendments to the terms of the carbon credit streaming agreement (the "Azuero Reforestation Stream”) with Azuero Reforestación Colectiva, S.A. (“ARC”), a wholly owned subsidiary of leading project developer Ponterra Ltd. (“Ponterra”), Microsoft Corporation (“Microsoft”) and Rubicon Carbon Capital LLC (“Rubicon”) for the ARC Restauro Azura proj ...
CORRECTION – Matador Technologies Inc. Announces Updated Terms of USD$100 Million Convertible Note Facility to Expand Bitcoin Holdings
Globenewswire· 2025-12-16 00:00
Key Highlights Strategic Capitalization: Matador has amended the terms of its previously announced USD$100 million convertible note facility with ATW Partners, with an initial USD$10.5 million tranche signed. Exclusive Use of Proceeds: Capital will be used solely to purchase Bitcoin to drive Bitcoin-per-share (BPS) growth. Institutional Partnership: ATW is a leading U.S.-based institutional investor focused on innovative growth-stage financing. Scalable Structure: Convertible note structure allows for equit ...
Trump’s $100,000 H-1B fee threatens Indian IT firms’ US hiring model
BusinessLine· 2025-12-15 23:59
President Donald Trump’s $100,000 price tag for new H-1B workers hired from outside the US will have punishing effects for the IT outsourcing and staffing industries that have long been a target of both parties.The fee is the biggest restriction the Trump administration has imposed so far on employment of skilled foreign workers.A Bloomberg News analysis found it will have a disproportionate impact on multinational staffing firms that act as middlemen for companies seeking H-1B workers. Those middlemen incl ...
South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi
Reuters· 2025-12-15 23:57
South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to develop and sell the biotech company's experimental Alzheimer's disease treat... ...
Affirm CEO details no-fee lending model: 'We have total alignment with our consumers'
CNBC· 2025-12-15 23:56
In a Monday interview with CNB's Jim Cramer, Affirm CEO Max Levchin reviewed his company's strategy, suggesting the buy now, pay later outfit benefits from not charging its customers late fees."We have total alignment with our consumers. If they don't pay us back, we just lose money," Levchin said. "There's no magic in the business model, and that transparency aligns us fully with that person."According to Levchin, late fees aren't necessary "if you get really good at underwriting." He advocated for more cl ...